Share
Figure 2
Overall Survival - Excluding Patients with Primary Platinum-Refractory Disease and ≥4 Prior Lines
Format
PNGSource
Corcept Therapeutics IncorporatedDownloads
About Us
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases, financial disclosures and multimedia content to media, investors, and consumers worldwide.
© 2025 Digital Media Innovations, LLC. All rights reserved.